Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2022 R21 RFA-CA-21-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy Active
2022 R21 CA21-003 KNOWLES, DAVID ARTHUR NEW YORK GENOME CENTER A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer Active
2021 R21 CA20-017 HAINER, SARAH JANE UNIVERSITY OF PITTSBURGH AT PITTSBURGH Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN Active
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2023 R33 RFA-CA-22-002 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck Active
2022 R21 CA21-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy Active
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2002 R21 PAR-01-104 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) PROTEIN LOCALIZATION: MULTI-APERTURE NEAR-FIELD OPTICS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
1999 R21 PAR-98-067 BASEDOW, ROBERT W RAYTHEON SYSTEMS COMPANY HYPERSPECTRAL SYSTEM FOR MOLECULAR ANALYSIS OF CANCER Complete
2001 R33 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2003 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2007 R21 RFA-CA-07-003 ROGERS, RICK HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) SAMPLE PREP METHODS TO ALLOW AUTOMATED 3D ANALYSIS OF MICROVESSEL MORPHOLOGY Complete
2010 R21 RFA-CA-09-004 POPESCU, GABRIEL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN LABEL FREE IMAGING OF BLOOD SMEARS AND TISSUE BIOPSIES Complete
2013 R44 RFA-CA-08-011 DUFFY, DAVID C QUANTERIX CORPORATION SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS Complete
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Complete
2000 R43 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2002 R44 PAR-99-101 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. LIGHT-UP PNA ARRAYS Complete
2006 R33 RFA-CA-06-002 BRENT, ROGER VTT/MSI MOLECULAR SCIENCES INSTITUTE TADPOLE ASSAYS FOR THE MOLECULAR ASSESSMENT OF CANCER Complete
2009 R21 RFA-CA-08-006 BURBULIS, IAN E VTT/MSI MOLECULAR SCIENCES INSTITUTE PCR FOR CARBOHYDRATE CANCER BIOMARKERS Complete
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Complete
2000 R21 PAR-99-102 PALLAVICINI, MARIA G. UNIVERSITY OF CALIFORNIA SAN FRANCISCO PROTEIN SIGNATURES OF LEUKEMIC CELLS Complete
2002 R33 PAR-99-100 ISSA, JEAN-PIERRE J UNIVERSITY OF TEXAS MD ANDERSON CAN CTR NEOPLASIA AND METHYLATED CPG ISLANDS AMPLIFICATION Complete
2005 R33 RFA-CA-05-003 D'ERRICO, FRANCESCO YALE UNIVERSITY CHEMOTHERAPY WITH INJECTABLE MICRODROPLETS Complete
2008 R33 RFA-CA-07-036 VIDAL, MARC DANA-FARBER CANCER INST APPLICATION OF TECHNOLOGIES FOR INTERACTOME NETWORK ANALYSES OF CANCER MUTATIONS Complete
2011 R33 RFA-CA-10-004 JU, JINGFANG STATE UNIVERSITY NEW YORK STONY BROOK IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED TARGETS BY TRIP-CHIP/SEQ Complete
2015 R33 RFA-CA-14-004 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN-MADISON SCALABLE CANCER GENOMICS VIA NANOCODING AND SEQUENCING Complete
2015 R33 RFA-CA-14-004 YEAKLEY, JOANNE MULLIGAN BIOSPYDER TECHNOLOGIES, INC. RASL-SEQ EXPRESSION PROFILING OF FFPE TISSUES Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2002 R21 PAR-01-104 VIDAL, MARC DANA-FARBER CANCER INSTITUTE A C. ELEGANS LOCALIZATION-OF-EXPRESSION MAPPING PROJECT Complete
2005 R21 RFA-CA-05-002 POOLE, LESLIE B WAKE FOREST UNIVERSITY HEALTH SCIENCES PROFILING OF REDOX-SENSITIVE SIGNALING PROTEINS Complete
2008 R21 RFA-CA-07-033 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY NANOBIOSENSING METHOD FOR POINT MUTATION DETECTION OF CANCER Complete
2011 R21 RFA-CA-10-001 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL ENHANCED FORMALIN FIXATION TO IMPROVE TESTS ON SOLID TISSUES Complete
2015 R21 RFA-CA-14-003 IAFRATE, ANTHONY JOHN MASSACHUSETTS GENERAL HOSPITAL HIGHLY MULTIPLEXED FISH FOR IN SITU GENOMICS Complete
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Complete
1999 R21 PAR-98-067 BRADLEY, ALLAN BAYLOR COLLEGE OF MEDICINE DEVELOPMENT OF BAC ARRAY COMPARITIVE GENOMIC HYBRIDIZATI Complete
2001 R33 PAR-99-100 HUNTER, IAN W MASSACHUSETTS INSTITUTE OF TECHNOLOGY ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT Complete
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2007 R21 RFA-CA-07-003 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROFLUIDIC CHANNELS FOR HIGH DENSITY, HIGH PERFORMANCE CULTURE ASSAYS Complete
2010 R21 RFA-CA-09-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER METHODS FOR THE ANALYSIS OF TUMOR EXTRACELLULAR MATRIX Complete

Pages